Evaluation of Oxygen Delivery Methods in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)

Reflections of Oxygen Delivery Methods Applied in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) on Blood Gas and Spirometer Measurements

To examine the effects of oxygen therapy methods applied as indicated in COPD acute exacerbations on blood gas results and spirometric measurements.

Patients requiring non-invasive ventilation will be divided into two groups: one group will receive NIMV in the form of Continuous Positive Airway Pressure (CPAP) or Bi-level Positive Airway Pressure (BiPAP). The other group will receive EzPAP® (a non-invasive positive airway pressure device). For both groups, blood gas results and hand-held spirometer parameters, including Forced Vital Capacity (FVC), Peak Expiratory Flow (PEF), and Forced Expiratory Volume in one second (FEV1), will be evaluated before and after the application.It is aimed to evaluate the effect of COPD noninvasive treatment methods on hospitalization and mortality processes.

Inclusion Criteria:

• Patients with acute exacerbation of COPD,
• Those without a history of trauma,
• Patients who have not undergone any lung surgery previously,
• Patients capable of providing written and verbal consent.

Exclusion Criteria:

• Patients without acute exacerbation of COPD,
• Pregnancy, suspected pregnancy,
• Those who have undergone any lung surgery previously,
• Patients with a history of trauma,
• Intubated patients and those not compliant with treatments,
• Patients unable to provide written and verbal consent.